Health AI in the 1st Week of April

Healthcare Triangle (US): Integrated an enterprise-grade agentic AI platform into its customer engagement offering, adding multilingual automation, human-like voice interactions, and real-time lead scoring and routing. [Link]

Viz.ai (US): Launched Viz Agent Studio, a new capability within its Viz.ai One platform that allows health systems to build and scale AI care pathways from clinical guidelines using natural language. The aim is to embed standardized care workflows more consistently across everyday operations. [Link]

UnitedHealthcare (US): Introduced Avery, a generative AI companion that helps members with 24/7 administrative and navigation tasks. [Link]

OpenEvidence (US): Launched Coding Intelligence™, a new feature that automatically suggests ICD-10 diagnoses, CPT codes, and E/M levels from clinical documentation to help physicians code visits faster and capture reimbursement more accurately. [Link]

Legion Health (US): Plans to launch an AI psychiatry tool in Utah that can renew certain lower-risk maintenance medications, with initial doctor oversight before broader autonomous use. [Link]

Butterfly Network (US): Achieved FDA clearance for an AI-powered ultrasound tool that estimates gestational age in under two minutes without requiring users to capture or interpret images or perform fetal biometric measurements. The tool is designed to expand access to prenatal imaging in rural and low-resource settings. [Link]

SPN Health (UK): Launched a preventative health offering starting with VO2 max testing, which the founder describes as a “Formula 1 pitstop for your health.” [Link]

Philips (Netherlands): Secured FDA 510(k) clearance for an AI-guided software tool that merges live ultrasound and X-ray images to support minimally invasive mitral valve repair. Philips said the tool is designed to help clinicians navigate these complex procedures, with mitral regurgitation affecting more than 35 million adults worldwide. [Link]

US State Legislatures (US): Multiple states advanced or enacted AI bills covering chatbots, provenance, and healthcare use, including restrictions on AI making certain mental health or therapy-related claims. [Link]

Apple (US): Updating the App Store to show whether apps are regulated medical devices in the EEA, UK, and US. Developers of qualifying apps must now provide a regulated medical device status in App Store Connect, along with relevant regulatory information such as contact details and safety information. [Link]

NHS Confederation (UK): Published a guide on clinical AI in mental health that emphasises robust governance, clinical evidence, and patient safety. It also draws a clear distinction between regulated clinical AI tools used in NHS care and unregulated consumer chatbots often used for mental wellbeing. [Link]

NHS Sussex (UK): Published co-designed guiding principles for AI use in healthcare, developed with its Digital and Data People’s Panel. The framework says AI should support, not replace, human decision-making, and emphasizes transparency, informed consent, accountability, and accessible feedback channels. [Link]

Care Quality Commission (UK): Released an algorithmic transparency record for its risk categorisation tool, which generates around 46,000 monthly scores to help prioritise care inspection activity. [Link]

U.S. Health Systems (US): A survey of 120 U.S. health systems found 75% were using at least one AI application in 2026, up from 59% in 2025, as adoption rises under workforce and financial pressure. [Link]

Sepsis Trajectories: A machine learning model trained on 47,936 ICU patients predicted sepsis deterioration trajectories, with a median 17.6-hour warning time before deterioration. [Link]

Hepatocellular Carcinoma Risk: An interpretable machine learning framework predicted liver cancer risk using routinely collected multimodal clinical data from over 900,000 individuals. [Link]

Pericardial Fat Prediction: Deep learning automatically measured pericardial adipose tissue from routine ECG-gated cardiac CT scans, and higher volume predicted long-term cardiovascular events beyond coronary calcium scoring. [Link]

Multimodal “Mirage Reasoning”: A study found that vision-language models can achieve top performance on medical benchmarks, including chest X-ray tasks, even without access to images, highlighting risks in how these systems are evaluated. [Link]

Bilingual AI Scribes: A prospective study evaluated an end-to-end Arabic-English ambient AI scribe across 55 real-world consultations, with mean documentation quality scores of 42.4/45 for Arabic and 37.8/40 for English. [Link]

Wolters Kluwer (Netherlands): Integrated CME credit earning and tracking into UpToDate Expert AI, allowing clinicians to earn credits when asking clinical questions within their workflow. [Link]

Tempus & Daiichi Sankyo (US/Japan): Partnered to use multimodal foundation models and real-world data for oncology biomarker discovery and patient stratification. [Link]

Insilico Medicine & Eli Lilly (US/China): Signed a $2.75 billion licensing and research deal covering preclinical oral drug candidates in selected disease areas. The collaboration gives Lilly exclusive rights to develop and commercialise those candidates, with Insilico receiving $115 million upfront plus potential milestones and royalties. [Link]

Lunit & CellCarta (South Korea/Canada): Partnered to combine Lunit’s AI digital pathology algorithms with CellCarta’s global laboratory and CDx infrastructure. [Link]

Manchester University NHS Foundation Trust & Microsoft (UK): announced it will add 6,500 Microsoft 365 Copilot licences each year and build an internal “Agent Factory” to automate routine operational and administrative tasks. [Link]

Wolters Kluwer (Netherlands): Integrated CME credit earning and tracking into UpToDate Expert AI, allowing clinicians to earn credits when asking clinical questions within their workflow. [Link]

Havas Life Mumbai & Shobiz (India): Partnered to deliver healthcare and pharma engagement in India using AI-powered tools, VR, AR, and MR. The focus is more immersive communication for healthcare professionals, patients, and caregivers. [Link]

Qualified Health (US): Raised $125 million to scale its healthcare AI evaluation and implementation platform. [Link]

Stedi (US): Raised $50 million in Series C funding to scale its modern healthcare clearinghouse platform. [Link]

Adonis (US): Raised $40 million in Series C funding to scale its agentic revenue cycle management platform. [Link]

Alan (France): Secured a strategic investment from elite athlete Kylian Mbappé as part of a push into proactive, gamified digital health. [Link]

Doctronic (US): Raised $40 million in Series B funding. The capital will be used to expand its autonomous, 24/7 clinical decision-making platform into pediatrics and to forge new partnerships with hospital systems and academic institutions. [Link]

eMed (US): Raised $200 million in Series A funding to expand its agentic AI platform. The technology helps employers manage population health and the rising costs of GLP-1 weight-loss drugs. [Link]

Soundable Health (US): Secured undisclosed pre-A follow-on funding from NAVER D2SF. The funds will expand its FDA-cleared acoustic AI diagnostics in the U.S. and adapt the technology for respiratory monitoring. [Link]

Collectly (US): Acquired patient finance competitor Pledge Health. The integration of AI workflow engines will fully automate pre-service financial clearance and cost estimates without expanding administrative headcount. [Link]

Vitality (US): Acquired onsite clinical coaching provider Ramp Health. The deal merges digital predictive AI analytics with in-person interventions for holistic chronic disease and occupational risk management. [Link]

Infosys (India): Acquired digital transformation firm Optimum Healthcare IT for a reported $465 million. [Link]